Plan Snapshot
- Plan Sponsor: Verve Therapeutics, INC.
- Sponsor EIN: 824800132
- Sponsor Address: 201 BROOKLINE AVE, BOSTON, MA, 02215
- Plan Type: 401(k)
- Total Participants: 275
- Total Assets: $24.5M
Key Plan Design Features
- Auto-Enrollment: Yes
- Auto-Escalation: No
- Allows Roth Contributions: No
- Participant Loans: No
- Participant-Directed Investments: Yes
- ERISA Section 404(c) Fiduciary Safe Harbor: Yes
Plan Financials by Year
| Year | Participants | Total Assets | Employer Contrib. | Employee Contrib. |
|---|---|---|---|---|
| 2024 | 275 | $24.5M | $1.9M | $4.4M |
| 2023 | 258 | $15.0M | $1.5M | $3.5M |
| 2022 | 207 | $7.1M | $974,917 | $2.2M |
Service Providers (Schedule C)
Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).
| Provider Name | Role | Direct Compensation | Indirect Compensation | Total Fees |
|---|---|---|---|---|
| GRAY, GRAY & GRAY LLP | Auditor | $759 | — | $759 |
Plan Fees & Expenses
Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.
- Total Service Provider Fees: $759
- Estimated Expense Ratio: 0.003% of plan assets
Historical Administrative Expenses
Breakdown of administrative expense categories reported on Form 5500 filings.
| Year | Total Admin Expenses | Investment Mgmt Fees | Contract Admin Fees | IQPA Audit Fees | Professional Fees |
|---|---|---|---|---|---|
| 2024 | $72,464 | $36,621 | — | $759 | — |
| 2023 | $638 | — | — | — | — |
| 2022 | $38,841 | — | $125 | — | — |